Spencer Feldman

A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment: © stock.adobe.com. The first patient with relapsed/refractory follicular lymphoma treated with PMB-CT01 in the phase 1 PMB-102 study has achieved complete remission one month after treatment, […]

DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin: © stock.adobe.com. Hearing loss was not linked to intra-arterial Paraplatin (carboplatin) when measured using distortion product otoacoustic emission measurement (DPOAE) testing in children with retinoblastoma, according to

The FDA granted fast track designation to Zai Lab’s ZL-1310 for extensive-stage small cell lung cancer after early data showed tumor shrinkage. The United States Food and Drug Administration (FDA) has granted fast track designation to ZL-1310 for the treatment of

Acoustic cluster therapy plus chemotherapy led to greater tumor shrinkage than chemotherapy alone in a phase 1 trial for colorectal liver metastases. The addition of acoustic cluster therapy to chemotherapy showed added benefit over chemotherapy alone in hard-to-treat patients with

Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies: © stock.adobe.com. Younger patients with lung cancer are more likely to have biomarkers in their cancer cells, which can guide targeted therapies for personalized

Melanoma care varies by stage: © stock.adobe.com. Melanoma treatment depends on stage. Early-stage cases may need only surgery, while deeper tumors might require lymph node evaluation and additional therapy, according to Dr. Douglas Johnson, who went on to say that

The first patient has received CX-801 plus Keytruda in a phase 1 trial for metastatic melanoma: © stock.adobe.com. The first patient has been dosed with CX-801 in combination with Keytruda (pembrolizumab) in an ongoing phase 1 dose escalation study, which

Managing symptoms is key to improving cognitive function in those receiving radiation therapy for prostate cancer: © stock.adobe.com. Managing fatigue, urinary issues and depression is essential for improving cognitive function in patients receiving radiation therapy for prostate cancer, though more

The FDA has approved Zynyz as a first-line treatment in advanced anal cancer. The United States Food and Drug Administration (FDA) has approved first-line treatment with Zynyz (retifanlimab-dlwr) in combination with the platinum-based carboplatin and paclitaxel chemotherapy for adult patients

Efti and Keytruda comboo achieves a 61% response rate in first-line advanced non-squamous non–small cell lung cancer: © stock.adobe.com. Efti (eftilagimod alpha) plus Keytruda (pembrolizumab) with chemotherapy achieved high response rates in the first-line treatment of patients with advanced or